These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 21750007)

  • 1. Prolonged intracerebral convection-enhanced delivery of topotecan with a subcutaneously implantable infusion pump.
    Sonabend AM; Stuart RM; Yun J; Yanagihara T; Mohajed H; Dashnaw S; Bruce SS; Brown T; Romanov A; Sebastian M; Arias-Mendoza F; Bagiella E; Canoll P; Bruce JN
    Neuro Oncol; 2011 Aug; 13(8):886-93. PubMed ID: 21750007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience.
    Grahn AY; Bankiewicz KS; Dugich-Djordjevic M; Bringas JR; Hadaczek P; Johnson GA; Eastman S; Luz M
    J Neurooncol; 2009 Nov; 95(2):185-197. PubMed ID: 19466380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of an effective implantable pump-infusion system for chronic convection-enhanced delivery of intracerebral topotecan in a large animal model.
    D'Amico RS; Neira JA; Yun J; Alexiades NG; Banu M; Englander ZK; Kennedy BC; Ung TH; Rothrock RJ; Romanov A; Guo X; Zhao B; Sonabend AM; Canoll P; Bruce JN
    J Neurosurg; 2020 Sep; 133(3):614-623. PubMed ID: 31374547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children.
    Anderson RC; Kennedy B; Yanes CL; Garvin J; Needle M; Canoll P; Feldstein NA; Bruce JN
    J Neurosurg Pediatr; 2013 Mar; 11(3):289-95. PubMed ID: 23240851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model.
    Saito R; Krauze MT; Noble CO; Drummond DC; Kirpotin DB; Berger MS; Park JW; Bankiewicz KS
    Neuro Oncol; 2006 Jul; 8(3):205-14. PubMed ID: 16723630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous intraputamenal convection-enhanced delivery in adult rhesus macaques.
    Fan X; Nelson BD; Ai Y; Stiles DK; Gash DM; Hardy PA; Zhang Z
    J Neurosurg; 2015 Dec; 123(6):1569-77. PubMed ID: 25932605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial.
    Spinazzi EF; Argenziano MG; Upadhyayula PS; Banu MA; Neira JA; Higgins DMO; Wu PB; Pereira B; Mahajan A; Humala N; Al-Dalahmah O; Zhao W; Save AV; Gill BJA; Boyett DM; Marie T; Furnari JL; Sudhakar TD; Stopka SA; Regan MS; Catania V; Good L; Zacharoulis S; Behl M; Petridis P; Jambawalikar S; Mintz A; Lignelli A; Agar NYR; Sims PA; Welch MR; Lassman AB; Iwamoto FM; D'Amico RS; Grinband J; Canoll P; Bruce JN
    Lancet Oncol; 2022 Nov; 23(11):1409-1418. PubMed ID: 36243020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety of combined intracerebral delivery of free gadolinium and targeted chemotherapeutic agent PRX321.
    Ding D; Kanaly CW; Cummings TJ; Herndon JE; Raghavan R; Sampson JH
    Neurol Res; 2010 Oct; 32(8):810-5. PubMed ID: 20021739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan.
    Bruce JN; Fine RL; Canoll P; Yun J; Kennedy BC; Rosenfeld SS; Sands SA; Surapaneni K; Lai R; Yanes CL; Bagiella E; DeLaPaz RL
    Neurosurgery; 2011 Dec; 69(6):1272-9; discussion 1279-80. PubMed ID: 21562434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and feasibility of convection-enhanced delivery of nimustine hydrochloride co-infused with free gadolinium for real-time monitoring in the primate brain.
    Sugiyama S; Saito R; Nakamura T; Yamashita Y; Yokosawa M; Sonoda Y; Kumabe T; Watanabe M; Tominaga T
    Neurol Res; 2012 Jul; 34(6):581-7. PubMed ID: 22709625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Cerebral Blood Volume Changes Predict Progression After Convection-Enhanced Delivery of Topotecan for Recurrent Malignant Glioma.
    Surapaneni K; Kennedy BC; Yanagihara TK; DeLaPaz R; Bruce JN
    World Neurosurg; 2015 Jul; 84(1):163-72. PubMed ID: 25772608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain.
    Saito R; Krauze MT; Bringas JR; Noble C; McKnight TR; Jackson P; Wendland MF; Mamot C; Drummond DC; Kirpotin DB; Hong K; Berger MS; Park JW; Bankiewicz KS
    Exp Neurol; 2005 Dec; 196(2):381-9. PubMed ID: 16197944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convection-enhanced delivery of free gadolinium with the recombinant immunotoxin MR1-1.
    Ding D; Kanaly CW; Bigner DD; Cummings TJ; Herndon JE; Pastan I; Raghavan R; Sampson JH
    J Neurooncol; 2010 May; 98(1):1-7. PubMed ID: 19898744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distribution, clearance, and brainstem toxicity of panobinostat administered by convection-enhanced delivery.
    Singleton WGB; Bienemann AS; Woolley M; Johnson D; Lewis O; Wyatt MJ; Damment SJP; Boulter LJ; Killick-Cole CL; Asby DJ; Gill SS
    J Neurosurg Pediatr; 2018 Sep; 22(3):288-296. PubMed ID: 29856296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convection enhanced delivery of different molecular weight tracers of gadolinium-tagged polylysine.
    Hardy PA; Keeley D; Schorn G; Forman E; Ai Y; Venugopalan R; Zhang Z; Bradley LH
    J Neurosci Methods; 2013 Sep; 219(1):169-75. PubMed ID: 23912025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery.
    Mamot C; Nguyen JB; Pourdehnad M; Hadaczek P; Saito R; Bringas JR; Drummond DC; Hong K; Kirpotin DB; McKnight T; Berger MS; Park JW; Bankiewicz KS
    J Neurooncol; 2004 May; 68(1):1-9. PubMed ID: 15174514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating infusate parameters for direct drug delivery to the brainstem: a comparative study of convection-enhanced delivery versus osmotic pump delivery.
    Rechberger JS; Power EA; Lu VM; Zhang L; Sarkaria JN; Daniels DJ
    Neurosurg Focus; 2020 Jan; 48(1):E2. PubMed ID: 31896090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning.
    Sampson JH; Brady ML; Petry NA; Croteau D; Friedman AH; Friedman HS; Wong T; Bigner DD; Pastan I; Puri RK; Pedain C
    Neurosurgery; 2007 Feb; 60(2 Suppl 1):ONS89-98; discussion ONS98-9. PubMed ID: 17297371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic Resonance Imaging-Based Assessment of Gadolinium-Conjugated Diethylenetriamine Penta-Acetic Acid Test-Infusion in Detecting Dysfunction of Convection-Enhanced Delivery Catheters.
    van Putten EH; Wembacher-Schröder E; Smits M; Dirven CM
    World Neurosurg; 2016 May; 89():272-9. PubMed ID: 26862025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal temozolomide drug delivery using convection enhanced delivery.
    Nordling-David MM; Yaffe R; Guez D; Meirow H; Last D; Grad E; Salomon S; Sharabi S; Levi-Kalisman Y; Golomb G; Mardor Y
    J Control Release; 2017 Sep; 261():138-146. PubMed ID: 28666727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.